Obesity and lung cancer – is programmed death ligand-1 (PD-1L) expression a connection?
Introduction In this retrospective study, the authors evaluated whether obesity-induced immunomodulation impacts the expression of programmed death ligand-1 (PD-1L) in lung cancer cells. Methods A retrospective cross-sectional study was performed. The study included 67 patients. The data did not ha...
Main Authors: | Jakub Krzysztof Gałązka, Marcin Czeczelewski, Tomasz Kucharczyk, Katarzyna Szklener, Sławomir Mańdziuk |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2024-01-01
|
Series: | Archives of Medical Science |
Subjects: | |
Online Access: | https://www.archivesofmedicalscience.com/Obesity-and-lung-cancer-is-programmed-death-ligand-1-PD-1L-expression-a-connection,175470,0,2.html |
Similar Items
-
Programmed death-1 (PD-1) ligand 1 and PD-1 ligand 2 expressions and their clinical relevance in colorectal cancer
by: Jee Hyun Ahn, et al.
Published: (2017-12-01) -
Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47
by: Huanhuan Hu, et al.
Published: (2023-01-01) -
Programmed death ligand 1 (PD-L1) expression in gastric cancer: literature review
by: T. N. Sotnikova, et al.
Published: (2023-07-01) -
Expression of Programmed Death Receptor 1 (PD-1) Gene and Its Ligand (PD-L1) in Patients with Laryngeal Cancer
by: Andrzej Kowalski, et al.
Published: (2021-07-01) -
Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors
by: Joon Seon Song, et al.
Published: (2019-10-01)